Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial

2015390 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: The Lancet

Volume 386, Issue 9993, pp. 552-561

Field-Weighted Citation Impact: 23.14